在治疗后的癌症幸存者中接种疫苗:多种疫苗范围审查
Kavita Renduchintala1, Mariana Arevalo2, Gabriella Fonseca3
1Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA; University of Chicago, 5801 S. Ellis Ave., Chicago, IL 60637, USA.
Vaccine
|May 27, 2024
概括
在癌症幸存者中,接种疫苗的比例有很大差异. 诸如社会人口结构,健康信念和提供者建议等因素影响疫苗接种率,需要针对性干预和临床指导方针.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 癌症幸存者代表了一个脆弱的人群,需要特定的疫苗接种策略.
- 了解接种疫苗的情况对于预防免疫受损个体的二次感染至关重要.
研究的目的:
- 为癌症幸存者群体中各种疫苗类型的疫苗接种率提供概述.
- 确定与癌症幸存者接种疫苗相关的因素,包括癌症幸存者的障碍和促进因素.
主要方法:
- 根据PRISMA的指导方针,在主要数据库 (Ovid MEDLINE,Embase,CINAHL Complete) 进行了全面的文献搜索.
- 包括的研究发表于2011年至2021年之间,重点是接种疫苗的癌症幸存者治疗后,并报告了吸收因素.
- 两名独立审稿人对文章和抽象数据进行了选,确保了严格的方法.
主要成果:
- 该审查包括31项研究,涵盖了各种疫苗类型,如流感,人类乳头瘤病毒和肺炎球菌疫苗.
- 疫苗接种率在不同疫苗和患者群体之间表现出相当大的变化.
- 影响吸收的关键因素包括社会人口统计学变量,健康信念,提供者建议和临床特征.
结论:
- 需要进一步的研究才能充分了解癌症幸存者接种疫苗的决定因素.
- 显然需要针对这一群体的疫苗接种策略量身定制的临床指南.
- 针对已确定障碍的多层次干预措施对于提高疫苗接种率至关重要.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
Cancer Vaccines
355
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
355
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Vaccinations
44.4K
Overview
44.4K
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
